Software eases pain of drug discovery
jane bird | financial times | 2 november 2015
PA’s Simon Kew, a technology expert, is quoted in the Financial Times in an article about drug discovery laboratories.
The article discusses data collection and analysis at Inventiva, a drug-discovery company, where scientists would spend long hours collecting data manually from machines to be analysed. The business has now deployed software that allows its devices to talk to each other and share data across the business.
PA's healthcare patch supports innovative telehealth solutions
Simon comments on the technologies that are used by these companies to collect their data. He says that, “drug discovery laboratories have a longstanding need to integrate data from multiple disparate sources with different formats and much of which is high volume and complex.”
He goes on to say: “The data can range from the genomic profile of a patient to a simple measurement such as a drug’s solubility. Not many in the industry have fully integrated all their data on to one information management system.”